IRIS
CANTARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.426
EU - Europa 27.437
AS - Asia 14.163
SA - Sud America 3.117
AF - Africa 361
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 20
AN - Antartide 1
Totale 77.588
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.062
GB - Regno Unito 7.221
RU - Federazione Russa 5.929
CN - Cina 4.901
SG - Singapore 4.714
IT - Italia 3.996
IE - Irlanda 2.964
BR - Brasile 2.691
UA - Ucraina 1.641
DE - Germania 1.438
SE - Svezia 1.421
HK - Hong Kong 1.331
FR - Francia 1.023
KR - Corea 976
VN - Vietnam 825
FI - Finlandia 818
IN - India 394
NL - Olanda 244
CA - Canada 186
TR - Turchia 166
AR - Argentina 157
PL - Polonia 157
JP - Giappone 139
BD - Bangladesh 119
ES - Italia 116
MX - Messico 113
IQ - Iraq 103
CI - Costa d'Avorio 96
ZA - Sudafrica 90
AT - Austria 81
CZ - Repubblica Ceca 77
EC - Ecuador 76
BE - Belgio 65
PK - Pakistan 65
ID - Indonesia 62
AU - Australia 55
UZ - Uzbekistan 49
IR - Iran 45
VE - Venezuela 41
CH - Svizzera 40
CL - Cile 40
SA - Arabia Saudita 40
MA - Marocco 38
CO - Colombia 34
KE - Kenya 30
AE - Emirati Arabi Uniti 27
LT - Lituania 27
EG - Egitto 23
PE - Perù 23
TN - Tunisia 22
DZ - Algeria 21
JO - Giordania 21
KZ - Kazakistan 21
UY - Uruguay 21
BG - Bulgaria 20
IL - Israele 19
PY - Paraguay 19
DK - Danimarca 18
EU - Europa 16
GR - Grecia 16
NP - Nepal 16
BY - Bielorussia 15
JM - Giamaica 14
MY - Malesia 14
PH - Filippine 14
RO - Romania 14
SN - Senegal 13
EE - Estonia 12
PT - Portogallo 12
AL - Albania 11
AZ - Azerbaigian 11
PA - Panama 11
BO - Bolivia 10
HU - Ungheria 10
LV - Lettonia 10
TW - Taiwan 9
AM - Armenia 8
BH - Bahrain 7
CY - Cipro 7
ET - Etiopia 7
KG - Kirghizistan 7
LB - Libano 7
MK - Macedonia 7
RS - Serbia 7
CR - Costa Rica 6
HN - Honduras 6
LU - Lussemburgo 6
LY - Libia 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
BB - Barbados 5
DO - Repubblica Dominicana 5
GE - Georgia 5
GY - Guiana 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
QA - Qatar 5
TH - Thailandia 5
BA - Bosnia-Erzegovina 4
Totale 77.521
Salva come PNG Salva come JPEG
Città #
Southend 6.689
Dallas 5.931
Fairfield 3.336
Singapore 2.976
Dublin 2.920
Ashburn 2.305
Chandler 1.711
Santa Clara 1.691
Moscow 1.631
Woodbridge 1.580
Wilmington 1.355
Houston 1.332
Jacksonville 1.315
Hong Kong 1.311
Seattle 1.261
Beijing 1.143
Cambridge 1.124
Hefei 1.077
Seoul 967
Siena 859
Ann Arbor 840
Menlo Park 655
Princeton 536
Munich 456
Nanjing 454
Milan 452
Los Angeles 437
New York 422
Helsinki 396
The Dalles 312
Boardman 258
São Paulo 251
Rome 240
Buffalo 232
San Mateo 232
Ho Chi Minh City 224
Florence 202
San Diego 200
Bengaluru 176
Council Bluffs 174
Düsseldorf 172
Dong Ket 161
Hanoi 152
Columbus 151
Nanchang 141
Redondo Beach 136
Shenyang 126
Chicago 115
London 111
Shanghai 103
Dearborn 100
Turku 100
Warsaw 98
Abidjan 96
Rio de Janeiro 87
Nuremberg 84
Tianjin 82
Changsha 81
Tokyo 78
Lauterbourg 77
Lappeenranta 76
Washington 73
Guangzhou 70
Hebei 68
Jiaxing 67
Brooklyn 65
Frankfurt am Main 65
Toronto 63
Belo Horizonte 62
Jinan 60
San Francisco 60
Denver 57
Stockholm 56
Brussels 54
Izmir 54
Orem 54
Montreal 52
Kunming 51
Portsmouth 51
Venezia 51
Norwalk 50
Atlanta 46
Málaga 46
Zhengzhou 46
Bologna 45
Olomouc 45
Boston 44
Chennai 44
Johannesburg 42
Tashkent 42
Phoenix 41
Brasília 39
Amsterdam 38
Kraków 38
Naples 38
Campinas 37
Curitiba 37
Poplar 37
Fremont 36
Mexico City 36
Totale 53.950
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 804
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 545
A first update on mapping the human genetic architecture of COVID-19 539
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 459
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 455
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 375
Genetic mechanisms of critical illness in COVID-19 332
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 330
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 330
Antirheumatic agents in covid-19: is IL-6 the right target? 330
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 328
An explainable model of host genetic interactions linked to COVID-19 severity 325
Antiangiogenic VEGF isoform in inflammatory myopathies 325
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 313
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 309
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 300
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 299
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 299
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 297
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 297
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 294
A case of amyloid myopathy in a patient with familial Mediterranean fever 292
Peripheral biomarkers' panel for severe COVID-19 patients 291
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 286
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 286
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 278
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 276
Colchicine myopathy and neuromyopathy: two cases with different characteristics 271
Pathogen-sugar interactions revealed by universal saturation transfer analysis 270
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) 268
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 267
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 266
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 264
Mapping the human genetic architecture of COVID-19 263
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups 262
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 261
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 259
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 257
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 253
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 252
Eosinophils in inflammatory muscle disorders: a morphologic and immunohistological study. 251
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 249
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 245
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 244
The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015 244
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 241
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 241
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 240
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 239
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 239
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 237
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry 236
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 232
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 231
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 231
Weekly oral alendronate in mevalonate kinase deficiency 229
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 226
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 226
Autoinflammatory disorders and patients with isolated serosal involvement. 225
Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial 225
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders 225
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 223
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 222
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria 222
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 221
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 220
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 220
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 219
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 218
Recommendations for the management of autoinflammatory diseases 217
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 216
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 215
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 214
Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure 214
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 213
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 213
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry 211
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 211
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 211
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 209
Untangling the Web of Systemic Autoinflammatory Diseases 209
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease 209
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations 208
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 207
Biological treatments in Behçet's disease: beyond anti-TNF therapy 206
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 206
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 206
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 205
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 205
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 205
Clinical and biochemical landmarks in systemic autoinflammatory diseases 204
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 204
Working the endless puzzle of hereditary autoinflammatory disorders. 203
Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene 202
Glucocorticoids in the management of systemic juvenile idiopathic arthritis 202
Effects of Spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis 201
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 201
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 200
Kawasaki syndrome and concurrent Coxsackie virus B3 infection 198
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 198
Totale 26.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.335 0 0 0 0 0 992 276 985 409 587 454 632
2021/20225.082 494 567 335 334 286 183 227 204 365 627 508 952
2022/20236.263 409 420 735 889 618 1.264 238 503 653 135 245 154
2023/20245.282 237 162 483 278 230 1.337 1.538 206 43 161 163 444
2024/202514.765 600 711 1.546 803 1.638 827 654 833 1.019 710 1.492 3.932
2025/202622.888 2.533 5.427 4.548 4.077 5.896 407 0 0 0 0 0 0
Totale 79.214